BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8019465)

  • 21. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
    Sahi H; Zein NN; Mehta AC; Blazey HC; Meyer KH; Budev M
    J Heart Lung Transplant; 2007 May; 26(5):466-71. PubMed ID: 17449415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
    Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F
    Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.
    Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB
    Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation.
    Fujii Y; Kaku K; Tanaka M; Kaneko T; Matumoto N; Shinohara K
    Bone Marrow Transplant; 1994 May; 13(5):523-6. PubMed ID: 7519934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T
    N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients.
    Töz H; Nart D; Turan I; Ersöz G; Seziş M; Aşçi G; Ozkahya M; Zeytinoğlu A; Erensoy S; Ok E
    Clin Transplant; 2009; 23(5):723-31. PubMed ID: 19573091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver disease after bone marrow transplantation--the Taiwan experience.
    Chen PM; Liu JH; Fan FS; Hsieh RK; Wei CH; Liu RS; Tzeng CH
    Transplantation; 1995 Apr; 59(8):1139-43. PubMed ID: 7732560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
    Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
    Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinfection of liver graft by hepatitis C virus after liver transplantation.
    Féray C; Samuel D; Thiers V; Gigou M; Pichon F; Bismuth A; Reynes M; Maisonneuve P; Bismuth H; Bréchot C
    J Clin Invest; 1992 Apr; 89(4):1361-5. PubMed ID: 1313453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.